Devin J Burke1, Alison Seitz2, Oluwatobi Aladesuru3, Matthew S Robbins2, Judy H Ch'ang4. 1. Division of Neurocritical Care, Weill Cornell Medicine, New York Presbyterian, 525 East 68th St, RM F610, New York, NY, 10065, USA. 2. Department of Neurology, Weill Cornell, New York Presbyterian, New York, NY, USA. 3. Weill Cornell Medical College, New York, NY, USA. 4. Division of Neurocritical Care, Weill Cornell Medicine, New York Presbyterian, 525 East 68th St, RM F610, New York, NY, 10065, USA. jhc9010@med.cornell.edu.
Abstract
PURPOSE OF REVIEW: While traditionally encountered in ambulatory settings, bruxism occurs in patients with a variety of acute neurologic illnesses including encephalitis, intracerebral hemorrhage, traumatic brain injury, hypoxic-ischemic encephalopathy, and acute ischemic stroke. Untreated bruxism in acute neurologic illness can lead to tooth loss, difficulty in mouth care resulting in recurrent aspiration pneumonia, endotracheal tube dislodgement, and even tongue laceration or amputation. Inpatient clinicians should be aware of the etiologies and management strategies for bruxism secondary to acute neurologic illness. RECENT FINDINGS: Management strategies for bruxism are varied and include pharmacologic and non-pharmacologic therapies in addition to onabotulinumtoxinA (BoNT-A). Bruxism impacts patients with a variety of acute neurologic illnesses, and emerging evidence suggests successful and safe treatment strategies.
PURPOSE OF REVIEW: While traditionally encountered in ambulatory settings, bruxism occurs in patients with a variety of acute neurologic illnesses including encephalitis, intracerebral hemorrhage, traumatic brain injury, hypoxic-ischemic encephalopathy, and acute ischemic stroke. Untreated bruxism in acute neurologic illness can lead to tooth loss, difficulty in mouth care resulting in recurrent aspiration pneumonia, endotracheal tube dislodgement, and even tongue laceration or amputation. Inpatient clinicians should be aware of the etiologies and management strategies for bruxism secondary to acute neurologic illness. RECENT FINDINGS: Management strategies for bruxism are varied and include pharmacologic and non-pharmacologic therapies in addition to onabotulinumtoxinA (BoNT-A). Bruxism impactspatients with a variety of acute neurologic illnesses, and emerging evidence suggests successful and safe treatment strategies.
Authors: Diana Vlăduțu; Sanda Mihaela Popescu; Răzvan Mercuț; Mihaela Ionescu; Monica Scrieciu; Adina Dorina Glodeanu; Andreea Stănuși; Ana Maria Rîcă; Veronica Mercuț Journal: Int J Environ Res Public Health Date: 2022-04-29 Impact factor: 4.614